Asia

Malaysia reports 5,501 new COVID-19 infections, 45 new deaths

Kuala Lumpur [Malaysia], November 27 (ANI/Xinhua): Malaysia reported 5,501 new COVID-19 infections as of midnight Friday, bringing the national total to 2,614,480, according to the health ministry.

ANI Nov 27, 2021 09:54 IST

Kuala Lumpur [Malaysia], November 27 (ANI/Xinhua): Malaysia reported 5,501 new COVID-19 infections as of midnight Friday, bringing the national total to 2,614,480, according to the health ministry.
Twenty-five of the new cases is imported, with 5,476 being local transmissions, data released on the ministry's website showed.
Another 45 more deaths have been reported, bringing the death toll to 30,240.
About 6,664 patients have been released after recovery, bringing the total number of cured and discharged to 2,516,693.
There are 67,547 active cases, 519 are being held in intensive care and 267 of those are in need of assisted breathing.
The country reported 113,741 vaccine doses administered on Friday alone. About 78.8 per cent of the population have received at least one dose and 76.8 per cent are fully vaccinated. (ANI/Xinhua)

Tags:

Malaysia COVID-19 Health

Get the App

India consistently supported Maldives in crisis: Mohamed Nasheed

2026-03-12T17:24:56.194121+00:00 IST

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Europe

Indian Rights Activist raises cadaver organ donation issue at UN

2026-03-12T14:23:46.827538+00:00 IST

Gobind Gurbani, speaking through video conference, drew attention to the growing gap between the number of patients requiring organ transplants and the limited availability of donated organs.

Asia

Policy delays leave Pakistan short of critical medicines

2026-03-12T09:29:30.117743+00:00 IST

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Middle East